CDT Equity ( (CDT) ) has released a notification of late filing.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CDT Equity Inc. has filed a Form 12b-25 to notify investors of a delayed Form 10-K (Yearly Report) for the fiscal year ended December 31, 2025. The company says it could not complete all financial statements and required disclosures in time for its Annual Report on Form 10-K (Yearly Report) deadline.
Management cites the need for additional time to compile financial information, suggesting that filing on the original schedule would have required unreasonable effort or expense. No specific issues such as auditor changes or internal control failures were disclosed.
CDT Equity expects to submit its Form 10-K (Yearly Report) within the permitted 15-calendar-day extension window. This means the filing should arrive shortly after the prescribed due date, assuming no further complications.
The company warns of a significantly larger net loss for 2025, projecting a loss of about $39.1 million, an increase of roughly $21.3 million from 2024. The deterioration is mainly driven by higher professional fees, travel costs, salaries, stock-based compensation, and contingent loss accruals.
These figures are preliminary and remain under review by CDT Equity’s independent registered public accounting firm, so actual results in the Form 10-K (Yearly Report) may differ. Investors should treat these as forward-looking statements that could change as the audit and final review are completed.
CDT Equity notes that all other required SEC reports over the past 12 months have been filed on time, signaling ongoing baseline compliance. The notification is signed by Chief Executive Officer Andrew Regan on April 1, 2026, underscoring executive-level oversight of the delayed filing and the company’s intent to complete the process within the allowed extension.
More about CDT Equity
CDT Equity Inc., formerly known as Conduit Pharmaceuticals Inc., is a U.S.-based company headquartered in Naples, Florida. The firm is listed under SEC file number 001-41245 and files regular reports under the Securities Exchange Act of 1934.
Average Trading Volume: 49,222
Technical Sentiment Signal: Sell
Current Market Cap: $24.08M
See more insights into CDT stock on TipRanks’ Stock Analysis page.